|
|
||||||||
Departments of Neurology (Drs. Cross and Raine), Pathology (Neuropathology) (Drs. Cross and Raine, and T. O'Mara), and Neuroscience (Dr. Raine), and the Rose F. Kennedy Center for Research in Mental Retardation and Human Development, Albert Einstein College of Medicine, Bronx, NY.
Although T cells play a pathogenetic role in MS, specific disease-inducing T cells have not been identified. T cells can be labeled and traced in adoptively transferred experimental autoimmune encephalomyelitis (EAE), a T-cell-mediated animal model for MS. We have followed the appearance and topographic localization of radiolabeled myelin basic protein-reactive (MBP+) T cells in evolving lesions as EAE extended to other regions of the CNS. By high-resolution autoradiography, we confirmed that MBP+ cells initially homed to perivascular regions in the lower spinal cord. With increasing time after cell transfer, labeled cells appeared in more recent lesions in rostral locations (upper spinal cord, cerebellum, and forebrain) and constituted a progressively smaller percentage of cells in lower spinal cord lesions. The presence of unlabeled inflammatory cells in the CNS parenchyma coincided temporally with clinical signs. In agreement with previous studies, we have shown that MBP+ cells constituted a minority (mean, <1.5%) of the total infiltrating cells and were most numerous in fresh lesions. We suggest that the perivascular regions of recent lesions would be the most likely areas to detect putative antigen-specific cells in MS lesions.
Address correspondence and reprint requests to Dr. Cedric S. Raine, Department of Pathology (Neuropathology), Albert Einstein College of Medicine, 1300 Morris Park Avenue, K-433, Bronx, NY 10461.
Supported by research grants JF 2042-A-2 and RG 1001-G-7 from the National Multiple Sclerosis Society, and NS 11920, NS 08952, and NS 07098 from the NINDS. A. Cross is a Harry Weaver Neuroscience Scholar of the National Multiple Sclerosis Society.
Received July 8, 1992. Accepted for publication in final form September 29, 1992.
This article has been cited by other articles:
![]() |
J. R. Lees, P. T. Golumbek, J. Sim, D. Dorsey, and J. H. Russell Regional CNS responses to IFN-{gamma} determine lesion localization patterns during EAE pathogenesis J. Exp. Med., October 27, 2008; 205(11): 2633 - 2642. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dasgupta, M. Jana, X. Liu, and K. Pahan Myelin Basic Protein-primed T Cells of Female but Not Male Mice Induce Nitric-oxide Synthase and Proinflammatory Cytokines in Microglia: IMPLICATIONS FOR GENDER BIAS IN MULTIPLE SCLEROSIS J. Biol. Chem., September 23, 2005; 280(38): 32609 - 32617. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dasgupta, M. Jana, X. Liu, and K. Pahan Role of Very-late Antigen-4 (VLA-4) in Myelin Basic Protein-primed T Cell Contact-induced Expression of Proinflammatory Cytokines in Microglial Cells J. Biol. Chem., June 13, 2003; 278(25): 22424 - 22431. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Reinhardt, D. C. Bullard, C. T. Weaver, and M. K. Jenkins Preferential Accumulation of Antigen-specific Effector CD4 T Cells at an Antigen Injection Site Involves CD62E-dependent Migration but Not Local Proliferation J. Exp. Med., March 17, 2003; 197(6): 751 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Chabot, F P Yong, D M Le, L M Metz, T Myles, and V W Yong Cytokine production in T lymphocyte-microglia interaction is attenuated by glatiramer acetate: a mechanism for therapeutic efficacy in multiple sclerosis Multiple Sclerosis, August 1, 2002; 8(4): 299 - 306. [Abstract] [PDF] |
||||
![]() |
M. Sixt, B. Engelhardt, F. Pausch, R. Hallmann, O. Wendler, and L. M. Sorokin Endothelial Cell Laminin Isoforms, Laminins 8 and 10, Play Decisive Roles in T Cell Recruitment across the Blood-Brain Barrier in Experimental Autoimmune Encephalomyelitis J. Cell Biol., May 28, 2001; 153(5): 933 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chabot and V. W. Yong Interferon beta-1b increases interleukin-10 in a model of T cell-microglia interaction: Relevance to MS Neurology, November 28, 2000; 55(10): 1497 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Aharoni, D. Teitelbaum, O. Leitner, A. Meshorer, M. Sela, and R. Arnon Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1 PNAS, October 10, 2000; 97(21): 11472 - 11477. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Fritz, X. Wang, and M.-L. Zhao Alterations in the Spinal Cord T Cell Repertoire During Relapsing Experimental Autoimmune Encephalomyelitis J. Immunol., June 15, 2000; 164(12): 6662 - 6668. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Croxford, K. Triantaphyllopoulos, O. L. Podhajcer, M. Feldmann, D. Baker, and Y. Chernajovsky Cytokine Gene Therapy in Experimental Allergic Encephalomyelitis by Injection of Plasmid DNA-Cationic Liposome Complex into the Central Nervous System J. Immunol., May 15, 1998; 160(10): 5181 - 5187. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Antel, E. McCrea, U. Ladiwala, Y.-f. Qin, and B. Becher Non-MHC-Restricted Cell-Mediated Lysis of Human Oligodendrocytes In Vitro: Relation with CD56 Expression J. Immunol., February 15, 1998; 160(4): 1606 - 1611. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |